USPTO serial 88873548
CURACYTE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- FERRELL, LUCY K
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CURACYTE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA
South San Francisco, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sean Ploen
Sean Ploen PLOEN LAW FIRM, PC724 Bielenberg Drive, #19SAINT PAUL, MN 55125-2620UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and biochemical products for industrial and scientific purposes, other than for medical purposes, namely, biological tissue cultures for industrial and scientific purposes and not for medical or veterinary purposes; reagents for scientific and research use | ACTIVE | — |
| 009 | Downloadable computer software for accessing a database featuring information in the medical field, namely, stem cell therapy related information; Downloadable software applications for telephones, tablets, computers allowing the access to information and consulting in the field of health; Downloadable software applications for telephones, tablets, computers allowing the access to information, monitoring and managing systems for the manufacture of advanced therapy and cell therapy medications; Downloadable databases in the field of manufacture of advanced therapy and cell therapy medications; downloadable electronic publications in the nature of electronic questionnaires in the field of advanced therapy and cell therapy medications; none of the foregoing in the field of pharmaceutical and veterinary products | ACTIVE | — |
| 010 | Medical equipment for the manufacturing of autologous and allogeneic biological cell therapies for medical and non-veterinary purposes, namely, fully integrated system for use in the creation of biological cell therapies for medical purposes; disposable single-use containers for solutions used for the manufacturing of autologous and allogeneic biological cell therapies, namely, bags, pouches, cartridges, rigid and semi-rigid containers for concentrates and solutions in solid or liquid form for medical use | ACTIVE | — |
| 037 | Installation, repair and maintenance services of medical and scientific apparatus and instruments for the manufacturing of autologous and allogeneic biological cell therapies | ACTIVE | — |
| 040 | Custom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies by pharmaceutical compounders; custom manufacturing for others, namely, manufacturing of pharmaceutical and veterinary preparations for health care, for the treatment of humans and animals suffering from diseases treated by cell therapy or regenerative medicine products by pharmaceutical compounders, namely, medicines for human purposes including medicines for experimental purposes, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies | ACTIVE | — |
| 042 | Research and development services in the field of cell therapies; Scientific research in human and animal cell therapy; Providing a bioinformatics platform as a service (PAAS) featuring computer software platforms for sequence data analysis in the field of manufacturing therapeutics; Medical and scientific research information in the field of cell therapy; Medical and scientific research in the field of cell therapy; technical assessments relating to design, namely, technical design consultation in the field of manufacture of advanced therapy and cell therapy medications; Technical research in the field of manufacture of advanced therapy and cell therapy medications; Software as a service (SaaS) services featuring software for assisting in the diagnosis of medical conditions in relation to advanced therapy and cell therapy medications; Cloud computing featuring software for use in assisting in the diagnosis of medical conditions; Providing search engines for the internet in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Computer services, namely, creating an online virtual community for registered users to organize groups and events, participate in discussion, and network with social and business communities in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Computer services, namely, hosting online web facilities for others for organizing colloquiums, events and interactive discussions, via communication networks in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Hosting digital content for users account in the Internet in the medical field and manufacturing of advanced therapy and cell therapy medications fields; designing websites for others, namely, designing online forums in the field of manufacture of advanced therapy and cell | ACTIVE | — |
| 044 | Stem cell therapy services; autologous and allogeneic cell therapy services in the nature of medical services, namely, diagnostic and therapeutic services in the field of genome sequencing and cell therapy, namely, genetic testing of humans for health assessment, diagnostic or treatment and medical purposes; autologous and allogeneic cell therapy services in the nature of medical services for the treatment of hematological malignancies; Medical and health care, namely, administration of cell therapy services for the treatment of hematological malignancies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cellares Corporation
- Other trademarks owned by Cellares Corporation
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 037
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CURACYTE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 18, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 18, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 11, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 9, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 9, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 9, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 9, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 7, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 7, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 7, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 27, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 27, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 27, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 3, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 29, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 29, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 29, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 16, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 29, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 21, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 21, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 1, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 13, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 30, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 30, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 30, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 2, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 2, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 2, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 11, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 11, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 11, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 9, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 9, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 9, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 6, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 18, 2020 | NWAP | NEW APPLICATION ENTERED | — |